Figure 1From: Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial Dose distribution a) pre- and b) post injection of spacer gel. Back to article page